CC BY-NC-ND 4.0 · Journal of Child Science 2018; 08(01): e7-e10
DOI: 10.1055/s-0038-1636930
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Maternal Age at Delivery and Enzyme Polymorphisms in Children with Type 1 Diabetes Mellitus

Fulvia Gloria-Bottini
1   Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
,
Anna Neri
1   Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
,
Patrizia Saccucci
1   Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
,
Maria Luisa Manca Bitti
2   Department of Medical Science, Pediatric Diabetes Unit, University of Rome Tor Vergata, Rome, Italy
,
Novella Rapini
2   Department of Medical Science, Pediatric Diabetes Unit, University of Rome Tor Vergata, Rome, Italy
,
Gabriele Renzetti
1   Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
,
Andrea Magrini
1   Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
,
Egidio Bottini
1   Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
› Author Affiliations
Further Information

Publication History

28 April 2017

11 January 2018

Publication Date:
05 March 2018 (online)

Abstract

Fetal genetic adaptation to environment of aging women could result in positive selection of genes that during extrauterine life increases the risk of type 1 diabetes mellitus (T1DM). We have examined the distribution of three genetic polymorphisms (acid phosphatase locus 1 [ACP1], p53 codon 72, and PTPN22) involved in T1DM risk in relation to maternal age at delivery. p53 codon 72 was determined in 281 T1DM children, ACP1 in 207 children, and PTPN22 in 216 children. Controls (blood donors) were 351 for ACP1, 271 for PTPN22, and 730 for p53 codon 72. Genotypes were determined by DNA analysis. The proportions of the three genotypes associated with T1DM are much greater in T1DM children from older mothers than in those from young mothers and in controls. The data support the hypothesis that advanced maternal age favors a positive selection of genes more adapted to the uterine environment of older women: these genes predispose to T1DM during extrauterine life.

 
  • References

  • 1 Flood TM, Brink SJ, Gleason RE. Increased incidence of type I diabetes in children of older mothers. Diabetes Care 1982; 5 (06) 571-573
  • 2 Tuvemo T, Dahlquist G, Frisk G. , et al. The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children–o evidence of increased antibody frequency. Diabetologia 1989; 32 (10) 745-747
  • 3 Bingley PJ, Douek IF, Rogers CA, Gale EA. ; Bart's-Oxford Family Study Group. Influence of maternal age at delivery and birth order on risk of type 1 diabetes in childhood: prospective population based family study. BMJ 2000; 321 (7258): 420-424
  • 4 Bottini N, Meloni GF, Lucarelli P. , et al. Risk of type 1 diabetes in childhood and maternal age at delivery, interaction with ACP1 and sex. Diabetes Metab Res Rev 2005; 21 (04) 353-358
  • 5 Gloria-Bottini F, Saccucci P, Meloni GF. , et al. Study of factors influencing susceptibility and age at onset of type 1 diabetes: a review of data from Continental Italy and Sardinia. World J Diabetes 2014; 5 (04) 557-561
  • 6 Stene LC, Magnus P, Lie RT, Søvik O, Joner G. Maternal and paternal age at delivery, birth order, and risk of childhood onset type 1 diabetes: population based cohort study. BMJ 2001; 323 (7309): 369-379
  • 7 Wang MH, vom Saal FS. Maternal age and traits in offspring. Nature 2000; 407 (6803): 469-470
  • 8 Bottini E, Meloni GF, MacMurray J, Ammendola M, Meloni T, Gloria-Bottini G. Maternal age and traits of offspring in humans. Placenta 2001; 22 (8–9): 787-789
  • 9 Gloria-Bottini E, Cosmi E, Nicotra M, Cosmi EV, Bottini E. Is delayed childbearing changing gene frequencies in Western populations?. Hum Biol 2005; 77 (04) 433-441
  • 10 Saccucci P, Manca Bitti ML, Bottini N. , et al. Type 1 diabetes: evidence of interaction between ACP1 and ADA1 gene polymorphisms. Med Sci Monit 2009; 15 (10) CR511-CR517
  • 11 Manca Bitti ML, Saccucci P, Bottini E, Gloria-Bottini F. p53 codon 72 polymorphism and type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2010; 23 (03) 291-292
  • 12 Bottini N, Musumeci L, Alonso A. , et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36 (04) 337-338
  • 13 Spencer N, Hopkinson DA, Harris H. Quantitative differences and gene dosage in the human red cell acid phosphatase polymorphism. Nature 1964; 201: 299-300
  • 14 Bottini N, Bottini E, Gloria-Bottini F, Mustelin T. Low-molecular-weight protein tyrosine phosphatase and human disease: in search of biochemical mechanisms. Arch Immunol Ther Exp (Warsz) 2002; 50 (02) 95-104
  • 15 Bottini N, Stefanini L, Williams S. , et al. Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J Biol Chem 2002; 277 (27) 24220-24224
  • 16 Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 1987; 7 (02) 961-963
  • 17 Zheng SJ, Lamhamedi-Cherradi SE, Wang P, Xu L, Chen YH. Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function. Diabetes 2005; 54 (05) 1423-1428
  • 18 Vang T, Congia M, Macis MD. , et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005; 37 (12) 1317-1319
  • 19 Gloria-Bottini F, Ammendola M, Saccucci P, Pietropolli A, Magrini A, Bottini E. The association of PTPN22 polymorphism with endometriosis: effect of genetic and clinical factors. Eur J Obstet Gynecol Reprod Biol 2013; 169 (01) 60-63